Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Opportunistic infections news

Show

From To
Does CMV underlie the increased risk of cardiovascular disease in patients with HIV?

Cytomegalovirus (CMV) antibody levels are associated with some important markers of vascular disease in HIV-positive women, US researchers show in a study published in the online edition

Published
16 April 2012
By
Michael Carter
'Social networks' may explain high prevalence of MRSA colonization seen in patients with HIV

Infection with HIV per se does not increase the risk of colonisation with community-associated MRSA, according to US research published in the online edition of Clinical

Published
27 February 2012
By
Michael Carter
Cotrimoxazole prophylaxis reduces death rate by almost 60% in adults taking ART in low and middle-income countries

Cotrimoxazole significantly reduces death among adults on ART in low and middle-income countries, according to a systematic review and meta-analysis published in the October online edition of

Published
10 February 2012
By
Carole Leach-Lemens
Cotrimoxazole prophylaxis is cost-effective for people starting ART in sub-Saharan Africa

Achieving full coverage of cotrimoxazole prophylaxis during the first six months of antiretroviral therapy would be a highly cost-effective way of reducing early death among those with advanced

Published
10 February 2012
By
Carole Leach-Lemens
First-Ever Treatment Guidelines Released for Major Cause of Death of People Living with HIV

The World Health Organization (WHO) has issued the first-ever guidelines for the treatment of cryptococcal meningitis – a disease ranking among the top causes of death among people living with HIV/AIDS. However, access to some of the WHO-recommended medicines ranges from difficult to non-existent in developing countries.

Published
13 December 2011
From
MSF
New vaccine against pneumococcal disease approved for UK

A new vaccine that may be more suitable for preventing pneumococcal disease in people living with HIV has been approved in the United Kingdom. Prevenar 13, manufactured by

Published
30 November 2011
By
Keith Alcorn
HIV-Infected Patients Respond Poorly to Pneumococcal Vaccine

Antibody responses to pneumococcal vaccine are low among HIV-infected individuals, whether they receive it before they begin antiretroviral therapy (ART) or after at least 6 months of ART, according to a poster presented at the Infectious Diseases Society of America 49th Annual Meeting.

Published
04 November 2011
From
Medscape (requires registration)
Free cotrimoxazole improves retention in care among adults not yet eligible for ART

Providing free cotrimoxazole prophylaxis to adults not yet eligible for antiretroviral treatment in Nairobi, Kenya, improved retention in care by over 20% after one year when compared

Published
18 August 2011
By
Carole Leach-Lemens
HPTN 052: early treatment reduces serious illness by 40%

Early treatment in the HPTN 052 study of treatment as prevention reduced serious illness by around 40%, delegates at the Sixth International AIDS Society conference (IAS 2011)

Published
18 July 2011
By
Keith Alcorn
South Africa: Crucial HIV drug in short supply

US pharmaceutical company Bristol Meyers Squibb confirmed doctors’ reports of a widespread shortage in South African public hospitals of its antifungal drug amphotericin B, branded as Fungizone.

Published
28 June 2011
From
Business Day

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.